After nine months of constant battles with the COVID-19 pandemic, it seems Indonesia, Southeast Asia’s most populous country, is losing. Since Indonesia declared its first cases in March,
A team of immunology experts from research organisations in Belgium and the UK have come together to apply their pioneering research methods to put individuals’ COVID-19 response under
WEDNESDAY, Oct. 14, 2020 — Protective antibodies persist for months in patients who survive serious COVID-19 infections, according to a study published Oct. 8 in Science Immunology. Anita
Maintenance treatment with the PARP inhibitor rucaparib (Rubraca) was well tolerated and provided clinical responses among patients with advanced BRCA- or PALB2-mutated pancreatic cancer sensitive to platinum-based chemotherapy,
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
